APO Research
Talk to an analyst

APO RESEARCH · REPORT

ICAD (Intracranial Atherosclerotic Disease) Pathology

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.

Selected research

Market Analysis & Forecast

Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Analysis and Forecast 2026-2032

9 January 2026193 pages

Choose your research edition.

Industry ResearchICAD (Intracranial Atherosclerotic Disease) Pathology Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal ICAD (Intracranial Atherosclerotic Disease) Pathology Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal ICAD (Intracranial Atherosclerotic Disease) Pathology Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.

Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.

This report presents an overview of global market for ICAD (Intracranial Atherosclerotic Disease) Pathology, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of ICAD (Intracranial Atherosclerotic Disease) Pathology, also provides the sales of main regions and countries. Of the upcoming market potential for ICAD (Intracranial Atherosclerotic Disease) Pathology, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the ICAD (Intracranial Atherosclerotic Disease) Pathology sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global ICAD (Intracranial Atherosclerotic Disease) Pathology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for ICAD (Intracranial Atherosclerotic Disease) Pathology sales, projected growth trends, production technology, application and end-user industry.

ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Company

Stryker

Balt

TERUMO

MicroPort

Acandis

ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Type

Stent

PTA Balloon

ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Application

Hospital

Clinic

Other

ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ICAD (Intracranial Atherosclerotic Disease) Pathology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of ICAD (Intracranial Atherosclerotic Disease) Pathology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ICAD (Intracranial Atherosclerotic Disease) Pathology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, ICAD (Intracranial Atherosclerotic Disease) Pathology sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Stent Major Manufacturers Table 3. PTA Balloon Major Manufacturers Table 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends Table 9. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Drivers Table 10. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Opportunities and Challenges Table 11. ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Restraints Table 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2021-2026) & (US$ Million) Table 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2027-2032) & (US$ Million) Table 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2021-2026) Table 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2027-2032) Table 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2021-2026) & (Units) Table 19. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2027-2032) & (Units) Table 20. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2021-2026) Table 21. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2027-2032) Table 22. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Manufacturers (2021-2026) Table 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturers (2021-2026) Table 26. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 27. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers, Product Type & Application Table 30. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021-2026) & (US$ Million) Table 35. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2027-2032) & (US$ Million) Table 36. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2021-2026) Table 37. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2027-2032) Table 38. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type 2021 VS 2025 VS 2032 (Units) Table 39. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2026) & (Units) Table 40. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2027-2032) & (Units) Table 41. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2021-2026) Table 42. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2027-2032) Table 43. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2021-2026) & (USD/Unit) Table 44. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2027-2032) & (USD/Unit) Table 45. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021-2026) & (US$ Million) Table 47. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2027-2032) & (US$ Million) Table 48. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2021-2026) Table 49. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2027-2032) Table 50. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application 2021 VS 2025 VS 2032 (Units) Table 51. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2026) & (Units) Table 52. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2027-2032) & (Units) Table 53. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2021-2026) Table 54. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2027-2032) Table 55. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2021-2026) & (USD/Unit) Table 56. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2027-2032) & (USD/Unit) Table 57. Stryker Company Information Table 58. Stryker Business Overview Table 59. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 60. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio Table 61. Stryker Recent Development Table 62. Balt Company Information Table 63. Balt Business Overview Table 64. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 65. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio Table 66. Balt Recent Development Table 67. TERUMO Company Information Table 68. TERUMO Business Overview Table 69. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 70. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio Table 71. TERUMO Recent Development Table 72. MicroPort Company Information Table 73. MicroPort Business Overview Table 74. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 75. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio Table 76. MicroPort Recent Development Table 77. Acandis Company Information Table 78. Acandis Business Overview Table 79. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 80. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio Table 81. Acandis Recent Development Table 82. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021-2026) & (US$ Million) Table 83. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2027-2032) & (US$ Million) Table 84. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2026) & (Units) Table 85. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2027-2032) & (Units) Table 86. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Type (2021-2026) & (USD/Unit) Table 87. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Type (2027-2032) & (USD/Unit) Table 88. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021-2026) & (US$ Million) Table 89. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2027-2032) & (US$ Million) Table 90. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2026) & (Units) Table 91. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2027-2032) & (Units) Table 92. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Application (2021-2026) & (USD/Unit) Table 93. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Application (2027-2032) & (USD/Unit) Table 94. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 96. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 97. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 98. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2026) & (Units) Table 99. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2027-2032) & (Units) Table 100. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Country (2021-2026) & (USD/Unit) Table 101. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Country (2027-2032) & (USD/Unit) Table 102. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 103. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 104. Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 105. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2026) & (Units) Table 108. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2027-2032) & (Units) Table 109. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Type (2021-2026) & (USD/Unit) Table 110. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Type (2027-2032) & (USD/Unit) Table 111. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2026) & (Units) Table 114. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2027-2032) & (Units) Table 115. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Application (2021-2026) & (USD/Unit) Table 116. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Application (2027-2032) & (USD/Unit) Table 117. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 121. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2026) & (Units) Table 122. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2027-2032) & (Units) Table 123. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Country (2021-2026) & (USD/Unit) Table 124. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Country (2027-2032) & (USD/Unit) Table 125. Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 126. France ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 127. U.K. ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 128. Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 129. Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 130. Spain ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 131. Netherlands ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 132. Switzerland ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 133. Sweden ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 134. Poland ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 135. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021-2026) & (US$ Million) Table 136. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2027-2032) & (US$ Million) Table 137. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2026) & (Units) Table 138. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2027-2032) & (Units) Table 139. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Type (2021-2026) & (USD/Unit) Table 140. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Type (2027-2032) & (USD/Unit) Table 141. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021-2026) & (US$ Million) Table 142. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2027-2032) & (US$ Million) Table 143. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2026) & (Units) Table 144. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2027-2032) & (Units) Table 145. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Application (2021-2026) & (USD/Unit) Table 146. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Application (2027-2032) & (USD/Unit) Table 147. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2026) & (Units) Table 150. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2027-2032) & (Units) Table 151. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Type (2021-2026) & (USD/Unit) Table 152. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Type (2027-2032) & (USD/Unit) Table 153. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2026) & (Units) Table 156. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2027-2032) & (Units) Table 157. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Application (2021-2026) & (USD/Unit) Table 158. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Application (2027-2032) & (USD/Unit) Table 159. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 163. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2026) & (Units) Table 164. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2027-2032) & (Units) Table 165. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Country (2021-2026) & (USD/Unit) Table 166. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Country (2027-2032) & (USD/Unit) Table 167. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 168. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 169. India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 170. Australia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 171. Taiwan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 173. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2026) & (Units) Table 176. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2027-2032) & (Units) Table 177. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Type (2021-2026) & (USD/Unit) Table 178. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Type (2027-2032) & (USD/Unit) Table 179. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2026) & (Units) Table 182. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2027-2032) & (Units) Table 183. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Application (2021-2026) & (USD/Unit) Table 184. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Application (2027-2032) & (USD/Unit) Table 185. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 189. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021-2026) & (Units) Table 190. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2027-2032) & (Units) Table 191. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Country (2021-2026) & (USD/Unit) Table 192. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Country (2027-2032) & (USD/Unit) Table 193. Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 194. Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 195. Chile ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 196. Colombia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 197. Peru ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 199. Israel ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 200. UAE ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 201. Turkey ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 202. Iran ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 203. Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List Table 207. ICAD (Intracranial Atherosclerotic Disease) Pathology Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Image Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Share 2021 VS 2025 VS 2032 Figure 4. Stent Image Figure 5. PTA Balloon Image Figure 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2021-2032) & (US$ Million) Figure 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2021-2032) Figure 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (2021-2032) & (Units) Figure 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Sales YoY (2021-2032) & (Units) Figure 20. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales YoY (2021-2032) & (Units) Figure 21. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales YoY (2021-2032) & (Units) Figure 22. Asia (Excluding China) ICAD (Intracranial Atherosclerotic Disease) Pathology Sales YoY (2021-2032) & (Units) Figure 23. South America, Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales YoY (2021-2032) & (Units) Figure 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2021-2032) Figure 30. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 31. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2021-2032) Figure 33. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2021-2032) Figure 36. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 37. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2021-2032) Figure 39. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Type (2021-2032) Figure 40. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Type (2021-2032) Figure 41. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Application (2021-2032) Figure 42. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Application (2021-2032) Figure 43. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Country (2021-2032) Figure 44. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Country (2021-2032) Figure 45. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Type (2021-2032) Figure 46. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Type (2021-2032) Figure 47. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Application (2021-2032) Figure 48. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Application (2021-2032) Figure 49. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Country (2021-2032) Figure 50. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Country (2021-2032) Figure 51. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Type (2021-2032) Figure 52. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Type (2021-2032) Figure 53. China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Application (2021-2032) Figure 54. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Application (2021-2032) Figure 55. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Type (2021-2032) Figure 56. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Type (2021-2032) Figure 57. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Application (2021-2032) Figure 58. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Application (2021-2032) Figure 59. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Country (2021-2032) Figure 60. Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Country (2021-2032) Figure 61. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Type (2021-2032) Figure 62. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Type (2021-2032) Figure 63. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Application (2021-2032) Figure 64. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Application (2021-2032) Figure 65. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Country (2021-2032) Figure 66. SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Country (2021-2032) Figure 67. ICAD (Intracranial Atherosclerotic Disease) Pathology Value Chain Figure 68. Manufacturing Cost Structure Figure 69. ICAD (Intracranial Atherosclerotic Disease) Pathology Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Stent
  • PTA Balloon
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Stryker
  • Balt
  • TERUMO
  • MicroPort
  • Acandis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Type
  3. 1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Stent
  5. 1.2.3 PTA Balloon
  6. 1.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Application
  7. 1.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Dynamics
  1. 2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
  2. 2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Drivers
  3. 2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Opportunities and Challenges
  4. 2.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region
  3. 3.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2021-2026)
  5. 3.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Region (2027-2032)
  6. 3.2.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Region (2021-2032)
  7. 3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region
  9. 3.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2021-2026)
  11. 3.4.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Region (2027-2032)
  12. 3.4.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers
  2. 4.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers
  6. 4.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers, Product Type & Application
  13. 4.7 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market CR5 and HHI
  16. 4.8.2 2025 ICAD (Intracranial Atherosclerotic Disease) Pathology Tier 1, Tier 2, and Tier 3
5 ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Type
  1. 5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type
  2. 5.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Type (2021-2032)
  5. 5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type
  6. 5.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Type (2021-2032)
  9. 5.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type
6 ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Application
  1. 6.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application
  2. 6.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Application (2021-2032)
  5. 6.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application
  6. 6.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2021-2032)
  9. 6.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application
7 Company Profiles
  1. 7.1 Stryker
  2. 7.1.1 Stryker Company Information
  3. 7.1.2 Stryker Business Overview
  4. 7.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
  6. 7.1.5 Stryker Recent Developments
  7. 7.2 Balt
  8. 7.2.1 Balt Company Information
  9. 7.2.2 Balt Business Overview
  10. 7.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
  12. 7.2.5 Balt Recent Developments
  13. 7.3 TERUMO
  14. 7.3.1 TERUMO Company Information
  15. 7.3.2 TERUMO Business Overview
  16. 7.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
  18. 7.3.5 TERUMO Recent Developments
  19. 7.4 MicroPort
  20. 7.4.1 MicroPort Company Information
  21. 7.4.2 MicroPort Business Overview
  22. 7.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
  24. 7.4.5 MicroPort Recent Developments
  25. 7.5 Acandis
  26. 7.5.1 Acandis Company Information
  27. 7.5.2 Acandis Business Overview
  28. 7.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Portfolio
  30. 7.5.5 Acandis Recent Developments
8 North America
  1. 8.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type
  2. 8.1.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021-2032)
  3. 8.1.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2032)
  4. 8.1.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2021-2032)
  5. 8.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application
  6. 8.2.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021-2032)
  7. 8.2.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2032)
  8. 8.2.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2021-2032)
  9. 8.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country
  10. 8.3.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type
  2. 9.1.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021-2032)
  3. 9.1.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2032)
  4. 9.1.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2021-2032)
  5. 9.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application
  6. 9.2.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021-2032)
  7. 9.2.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2032)
  8. 9.2.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2021-2032)
  9. 9.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country
  10. 9.3.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type
  2. 10.1.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021-2032)
  3. 10.1.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2032)
  4. 10.1.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2021-2032)
  5. 10.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application
  6. 10.2.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021-2032)
  7. 10.2.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2032)
  8. 10.2.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type
  2. 11.1.1 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021-2032)
  3. 11.1.2 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2032)
  4. 11.1.3 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2021-2032)
  5. 11.2 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application
  6. 11.2.1 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021-2032)
  7. 11.2.2 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2032)
  8. 11.2.3 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2021-2032)
  9. 11.3 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country
  10. 11.3.1 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type
  2. 12.1.1 SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2021-2032)
  4. 12.1.3 SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2021-2032)
  5. 12.2 SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application
  6. 12.2.1 SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2021-2032)
  8. 12.2.3 SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2021-2032)
  9. 12.3 SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Country
  10. 12.3.1 SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Value Chain Analysis
  2. 13.1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Mode & Process
  6. 13.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors
  9. 13.2.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst